MCID: NNT004
MIFTS: 37

Neonatal Respiratory Failure malady

Categories: Fetal diseases, Respiratory diseases

Aliases & Classifications for Neonatal Respiratory Failure

Aliases & Descriptions for Neonatal Respiratory Failure:

Name: Neonatal Respiratory Failure 12 14 69
Respiratory Failure of Newborn 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11161
ICD10 33 P28.5
ICD9CM 35 770.84
SNOMED-CT 64 206317005 95619009
UMLS 69 C0521648

Summaries for Neonatal Respiratory Failure

MalaCards based summary : Neonatal Respiratory Failure, also known as respiratory failure of newborn, is related to respiratory failure and lipid-rich carcinoma. An important gene associated with Neonatal Respiratory Failure is ABCA3 (ATP Binding Cassette Subfamily A Member 3), and among its related pathways/superpathways are Metabolism of proteins and Phagosome. The drugs Beractant and Poractant alfa have been mentioned in the context of this disorder. Affiliated tissues include lung and kidney, and related phenotypes are mortality/aging and respiratory system

Related Diseases for Neonatal Respiratory Failure

Diseases related to Neonatal Respiratory Failure via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 35)
id Related Disease Score Top Affiliating Genes
1 respiratory failure 10.5
2 lipid-rich carcinoma 10.0 ABCA3 SFTPC
3 scn9a-related inherited erythromelalgia 10.0 SFTPA1 SFTPC
4 imperforate anus 10.0 SFTPB SFTPC
5 skull base neoplasm 9.9 SFTPB SFTPC
6 osteochondritis dissecans 9.9 ABCA3 SFTPB SFTPC
7 transverse myelitis 9.9 SFTPB SFTPD
8 ectodermal dysplasia with natal teeth, turnpenny type 9.9 SFTPA1 SFTPB SFTPC
9 cranial nerve malignant neoplasm 9.9 SFTPA1 SFTPD
10 pulmonary fibrosis and/or bone marrow failure, telomere-related, 1 9.9 SFTPB SFTPC
11 acute chest syndrome 9.9 SFTPC SFTPD
12 conjunctivochalasis 9.8 SFTPB SFTPC SFTPD
13 neurotrophic keratoconjunctivitis 9.8 SFTPB SFTPC SFTPD
14 adnp syndrome 9.8 SFTPB SFTPC SFTPD
15 malignant neoplasm of acoustic nerve 9.8 SFTPA1 SFTPC SFTPD
16 back pain 9.7 ABCA3 SFTPA1 SFTPB SFTPC
17 renal tubular acidosis 9.7 SFTPA1 SFTPC SFTPD
18 rectum squamous cell carcinoma 9.7 SFTPB SFTPC SFTPD
19 sensorineural hearing loss 9.7
20 anogenital venereal wart 9.6 ABCA3 SFTPB SFTPC SFTPD
21 nervous system cancer 9.6 ABCA3 SFTPB SFTPC SFTPD
22 subcorneal pustular dermatosis 9.6 ABCA3 SFTPB SFTPC SFTPD
23 bronchopulmonary dysplasia 9.6
24 congenital hypothyroidism 9.6
25 chlamydia 9.6
26 gestational diabetes 9.6
27 hypothyroidism 9.6
28 rhizomelic chondrodysplasia punctata 9.6
29 interstitial lung disease 9.6
30 lung disease 9.6
31 myotonic dystrophy 9.6
32 alveolar capillary dysplasia 9.6
33 aortic aneurysm, familial thoracic 6 9.6 SFTPA1 SFTPB SFTPC SFTPD
34 renal tubular dysgenesis, agt-related 9.4 ABCA3 SFTPA1 SFTPB SFTPC SFTPD
35 common wart 9.2 ABCA3 SFTPA1 SFTPB SFTPC SFTPD TRPS1

Graphical network of the top 20 diseases related to Neonatal Respiratory Failure:



Diseases related to Neonatal Respiratory Failure

Symptoms & Phenotypes for Neonatal Respiratory Failure

MGI Mouse Phenotypes related to Neonatal Respiratory Failure:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 mortality/aging MP:0010768 9.43 TRPS1 ABCA3 SFTPA1 SFTPB SFTPC SFTPD
2 respiratory system MP:0005388 9.1 ABCA3 SFTPA1 SFTPB SFTPC SFTPD TRPS1

Drugs & Therapeutics for Neonatal Respiratory Failure

Drugs for Neonatal Respiratory Failure (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 274)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1 Beractant Approved Phase 4,Phase 3 108778-82-1
2 Poractant alfa Approved Phase 4,Phase 3 129069-19-8
3
Ceftazidime Approved Phase 4 78439-06-2 5481173
4
Meropenem Approved, Investigational Phase 4 119478-56-7 64778 441130
5
Tobramycin Approved, Investigational Phase 4 32986-56-4 5496 36294
6
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
7
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1 10102-43-9 145068
8
Atropine Approved, Vet_approved Phase 4 5908-99-6, 51-55-8 174174
9
Morphine Approved, Investigational Phase 4,Phase 2,Phase 3 57-27-2 5288826
10
Ketamine Approved, Vet_approved Phase 4 6740-88-1 3821
11
Nitrous oxide Approved, Vet_approved Phase 4 10024-97-2 948
12
Propofol Approved, Investigational, Vet_approved Phase 4 2078-54-8 4943
13
Sevoflurane Approved, Vet_approved Phase 4,Phase 2,Phase 3 28523-86-6 5206
14
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
15
Nicotine Approved Phase 4 54-11-5 942 89594
16
Remifentanil Approved Phase 4,Phase 2 132875-61-7 60815
17
Epoprostenol Approved Phase 4 61849-14-7, 35121-78-9 5280427 5282411
18
Iloprost Approved, Investigational Phase 4,Phase 1,Phase 2 78919-13-8 6443959
19
Piperacillin Approved Phase 4 66258-76-2 43672
20
Tazobactam Approved Phase 4 89786-04-9 123630
21 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1
22 Pulmonary Surfactants Phase 4,Phase 3,Phase 2
23 Respiratory System Agents Phase 4,Phase 3,Phase 2,Phase 1
24 Anti-Bacterial Agents Phase 4,Phase 3,Phase 1
25 Antibiotics, Antitubercular Phase 4
26 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
27 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2,Phase 1
28 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
29 Bronchodilator Agents Phase 4,Phase 3,Phase 2,Phase 1
30 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
31 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
32 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
33 Vasodilator Agents Phase 4,Phase 3,Phase 2,Phase 1
34 Adjuvants, Anesthesia Phase 4
35 Anesthetics Phase 4,Phase 2,Phase 3
36 Mydriatics Phase 4
37 Analgesics Phase 4,Phase 3,Phase 2
38 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2
39 Anesthetics, General Phase 4,Phase 2,Phase 3
40 Anesthetics, Intravenous Phase 4,Phase 2
41 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
42 Hypnotics and Sedatives Phase 4,Phase 3,Phase 2
43 Antihypertensive Agents Phase 4,Phase 3,Phase 2,Phase 1
44 Antioxidants Phase 4,Phase 3,Phase 2,Phase 1
45 Endothelium-Dependent Relaxing Factors Phase 4,Phase 3,Phase 2,Phase 1
46 Anti-Arrhythmia Agents Phase 4,Phase 2,Phase 3
47 Cholinergic Agents Phase 4
48 Cholinergic Antagonists Phase 4
49 Muscarinic Antagonists Phase 4
50 Parasympatholytics Phase 4

Interventional clinical trials:

(show top 50) (show all 287)
id Name Status NCT ID Phase
1 Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations Unknown status NCT01941524 Phase 4
2 Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn Unknown status NCT01499238 Phase 4
3 Noninvasive Positive Airway Pressure in the Pediatric Emergency Department for the Treatment of Acute Asthma Exacerbations Unknown status NCT01497691 Phase 4
4 Efficacy Evaluation of Surfactant Administration Via Laryngeal Mask Airway Unknown status NCT01173237 Phase 4
5 Surfactant Administration During Spontaneous Breathing Unknown status NCT01329432 Phase 4
6 Cpap at Delivery Room for Preterm Infants Unknown status NCT01024361 Phase 4
7 Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis Unknown status NCT01044719 Phase 4
8 Inhaled Nitric Oxide by Oxygen Hood in Neonates Completed NCT00732537 Phase 4
9 Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely Completed NCT00390065 Phase 4
10 Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome Completed NCT02041546 Phase 4
11 Randomized Controlled Trial of Surfactant Delivery Via Laryngeal Mask Airway (LMA) Versus Endotracheal Intubation Completed NCT01042600 Phase 4
12 Standard Treatment Compliance of Participants, Effectiveness and Prognosis in Acute Respiratory Distress Syndrome Completed NCT02178982 Phase 4
13 Anesthesia for Retinopathy of Prematurity Completed NCT01955135 Phase 4
14 Effects of SEvoflurane on Gas Exchange and Inflammation in Patients With ARDS (SEGA Study) Completed NCT02166853 Phase 4
15 Clinical Study With an Enteral Formula With Symbiotic and DHA for Malnourished Children Completed NCT02128984 Phase 4
16 Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure Recruiting NCT01891500 Phase 4
17 Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome Recruiting NCT02164734 Phase 4
18 NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome Not yet recruiting NCT02901652 Phase 4
19 Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure. Terminated NCT00208078 Phase 4
20 Inhaled Aerosolized Prostacyclin for Pulmonary Hypertension Requiring Inhaled Nitric Oxide Terminated NCT02170519 Phase 4
21 Continuous Infusion Piperacillin-tazobactam for the Treatment of Cystic Fibrosis Terminated NCT01694069 Phase 4
22 Pre Hospital Evaluation of Video Laryngoscopy Withdrawn NCT01374061 Phase 4
23 A Study of Bi-Level Positive Airway Pressure (BIPAP) Versus Non Invasive Positive Pressure Ventilation (NIPPV) for Neonatal Respiratory Failure Unknown status NCT01318824 Phase 3
24 Use of Orotracheal Continuous Positive Airway Pressure (CPAP) in Newborns With Respiratory Failure Unknown status NCT01379820 Phase 2, Phase 3
25 Non Invasive Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants. Unknown status NCT01778829 Phase 3
26 Dexmedetomidine in Mechanically Ventilated Neonates With Single-Organ Respiratory Failure. Unknown status NCT01266252 Phase 3
27 Sildenofil in Persistent Pulmonary Hypertension in Newborns Unknown status NCT01558466 Phase 3
28 Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study) Completed NCT00814099 Phase 3
29 Prolonged Outcomes After Nitric Oxide (PrONOx) Completed NCT00234247 Phase 3
30 Study of a Novel Technique of Mechanical Ventilation in Patients With Severe Acute Respiratory Failure Completed NCT00637507 Phase 2, Phase 3
31 Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia Completed NCT01503801 Phase 2, Phase 3
32 Dexamethasone Therapy in VLBW Infants at Risk of CLD Completed NCT00011362 Phase 3
33 Prone-Supine Study II: The Effect of Prone Positioning for Patients Affected by Acute Respiratory Distress Syndrome Completed NCT00159939 Phase 3
34 NIV Strategies for RDS in Preterm Infants. NIV (Non Invasive Ventilation), RDS (Respiratory Distress Syndrome) Completed NCT02259400 Phase 2, Phase 3
35 Lung Open Ventilation to Decrease Mortality in the Acute Respiratory Distress Syndrome Completed NCT00182195 Phase 3
36 Protective Ventilation With Carbon Dioxide (CO2) -Removal Technique in Patients With Adult Respiratory Distress Syndrome (ARDS) Completed NCT00465309 Phase 3
37 Nasal Intermittent Positive Pressure Ventilation in Premature Infants (NIPPV) Completed NCT00433212 Phase 3
38 Inhaled Beclomethasone to Prevent Chronic Lung Disease Completed NCT00000576 Phase 3
39 Very Early Surfactant and NCPAP for Premature Infants With RDS Completed NCT00563641 Phase 3
40 Pulmonary And Renal Support During Acute Respiratory Distress Syndrome Completed NCT01239966 Phase 3
41 Interest of Using the Sevoflurane in the Prevention of Newborns Pain Completed NCT00420693 Phase 2, Phase 3
42 A Multi-center Trial to Determine if Curosurf® Reduces the Duration of Mechanical Ventilation in Very Preterm Infants Completed NCT01709409 Phase 3
43 Corticosteroids as Rescue Therapy for the Late Phase of Acute Respiratory Distress Syndrome Completed NCT00295269 Phase 3
44 Early Versus Delayed Enteral Feeding to Treat People With Acute Lung Injury or Acute Respiratory Distress Syndrome (The EDEN Study) Completed NCT00883948 Phase 3
45 A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn Recruiting NCT01720524 Phase 3
46 Safety And Efficacy Of Dexmedetomidine Sedation In Intubated Mechanically Ventilated Infants With Respiratory Failure Recruiting NCT02996058 Phase 2, Phase 3
47 Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Patients Having Acute Respiratory Distress Syndrome (ARDS) Recruiting NCT02622724 Phase 3
48 Mechanical cervicAl ripeninG for Women With PrOlongedPregnancies Recruiting NCT02907060 Phase 3
49 Vitamin D to Improve Outcomes by Leveraging Early Treatment Recruiting NCT03096314 Phase 3
50 A Phase III Efficacy and Safety Study of Intravenous Retosiban Versus Placebo for Women in Spontaneous Preterm Labor Recruiting NCT02377466 Phase 3

Search NIH Clinical Center for Neonatal Respiratory Failure

Genetic Tests for Neonatal Respiratory Failure

Anatomical Context for Neonatal Respiratory Failure

MalaCards organs/tissues related to Neonatal Respiratory Failure:

39
Lung, Kidney

Publications for Neonatal Respiratory Failure

Articles related to Neonatal Respiratory Failure:

(show top 50) (show all 79)
id Title Authors Year
1
Lung Rest During Extracorporeal Membrane Oxygenation for Neonatal Respiratory Failure-Practice Variations and Outcomes. ( 28504997 )
2017
2
Mortality of Neonatal Respiratory Failure from Chinese Northwest NICU Network. ( 27651118 )
2016
3
Neonatal respiratory failure due to ABCA3 deficiency. ( 28038995 )
2016
4
Venoarterial extracorporeal life support for neonatal respiratory failure: indications and impact on mortality. ( 27984316 )
2016
5
Neonatal Respiratory Failure with Retarded Perinatal Lung Maturation in Mice Caused by Reticulocalbin 3 Disruption. ( 26252542 )
2015
6
Effect of Change of Mechanical Ventilation Position on the Treatment of Neonatal Respiratory Failure. ( 25647746 )
2015
7
Successful primary use of VVDL+V ECMO with cephalic drain in neonatal respiratory failure. ( 26562372 )
2015
8
Venoarterial versus venovenous ECMO for neonatal respiratory failure. ( 24580762 )
2014
9
Exercise capacity, daily activity, and severity of fatigue in term born young adults after neonatal respiratory failure. ( 22724460 )
2014
10
Comparison of High Frequency Positive Pressure Mechanical Ventilation (HFPPV) With Conventional Method in the Treatment of Neonatal Respiratory Failure. ( 23983995 )
2013
11
Successful treatment of neonatal respiratory failure caused by a novel surfactant protein C p.Cys121Gly mutation with hydroxychloroquine. ( 23719253 )
2013
12
Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants. ( 22331337 )
2012
13
The pulmonary circulation in neonatal respiratory failure. ( 22954275 )
2012
14
Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufficiency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis. ( 20584796 )
2011
15
Rhizomelic chondrodysplasia punctata type 1 and fulminant neonatal respiratory failure, a case report and discussion of pathophysiology. ( 22052861 )
2011
16
Acute management of neonatal respiratory failure due to crossed ectopic obstructed megaureter in a duplicated pelvic kidney. ( 21050823 )
2011
17
Mortality of neonatal respiratory failure related to socioeconomic factors in Hebei province of China. ( 21150226 )
2011
18
Gestational diabetes: a strong independent risk factor for severe neonatal respiratory failure after 34 weeks. ( 21170541 )
2011
19
Neonatal respiratory failure due to a novel mutation in the surfactant protein C gene. ( 20118944 )
2010
20
Extracorporeal membrane oxygenation and term neonatal respiratory failure deaths in the United Kingdom compared with the United States: 1999 to 2005. ( 19593243 )
2010
21
Extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure. ( 19713207 )
2009
22
Extracorporeal membrane oxygenation for neonatal respiratory failure. ( 19712500 )
2009
23
Neonatal respiratory failure: a 12-month clinical epidemiologic study from 2004 to 2005 in China. ( 18450855 )
2008
24
Clinical correlations and pulmonary function at 8 years of age after severe neonatal respiratory failure. ( 17654569 )
2007
25
ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease. ( 17142158 )
2006
26
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. ( 16449030 )
2006
27
Neonatal respiratory failure associated with mutation in the surfactant protein C gene. ( 16355106 )
2006
28
Continuous negative extrathoracic pressure (CNEP) in neonatal respiratory failure: correction. ( 16740893 )
2006
29
[Neonatal respiratory failure associated with mutation in the surfactant protein C gene]. ( 15737281 )
2005
30
ECMO for neonatal respiratory failure. ( 15921148 )
2005
31
Acinar dysplasia: a rare cause of neonatal respiratory failure. ( 15174801 )
2004
32
Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure. ( 15520110 )
2004
33
Venovenous extracorporeal membrane oxygenation in neonatal respiratory failure: does routine, cephalad jugular drainage improve outcome? ( 15136997 )
2004
34
Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. ( 14654609 )
2003
35
Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the US. ( 14654622 )
2003
36
Neonatal respiratory failure. ( 12011671 )
2002
37
Late-onset, progressive sensorineural hearing loss after severe neonatal respiratory failure. ( 11981395 )
2002
38
Acute neonatal respiratory failure and Chlamydia trachomatis. ( 11287694 )
2001
39
Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. ( 11673202 )
2001
40
State of the art. Neonatal respiratory failure. ( 10855113 )
1999
41
Intratracheal pulmonary ventilation in neonatal respiratory failure. ( 9934880 )
1999
42
Experimental neonatal respiratory failure induced by lysophosphatidylcholine: effect of surfactant treatment. ( 9931201 )
1999
43
Which interventions for neonatal respiratory failure are effective? ( 9575272 )
1998
44
Alveolar capillary dysplasia with misalignment of the pulmonary veins: a rare but fatal cause of neonatal respiratory failure. ( 9880707 )
1998
45
Continuous negative extrathoracic pressure in neonatal respiratory failure. ( 8951269 )
1996
46
Early measurement of lung volume--a useful discriminator of neonatal respiratory failure severity. ( 8746375 )
1996
47
Clinical approaches to the use of high-frequency oscillatory ventilation in neonatal respiratory failure. ( 8732550 )
1996
48
A comparison of venovenous and venoarterial extracorporeal membrane oxygenation in the treatment of neonatal respiratory failure. ( 8874305 )
1996
49
A matched pairs analysis of venoarterial and venovenous extracorporeal life support in neonatal respiratory failure. ( 8573870 )
1995
50
Extracorporeal membrane oxygenation with veno-venous bypass and apneic oxygenation for treatment of severe neonatal respiratory failure. ( 8647586 )
1995

Variations for Neonatal Respiratory Failure

Expression for Neonatal Respiratory Failure

Search GEO for disease gene expression data for Neonatal Respiratory Failure.

Pathways for Neonatal Respiratory Failure

Pathways related to Neonatal Respiratory Failure according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.15 ABCA3 SFTPA1 SFTPB SFTPC SFTPD
2 11.59 SFTPA1 SFTPD
3
Show member pathways
11.44 SFTPA1 SFTPB SFTPC SFTPD
4 11.17 SFTPA1 SFTPC
5
Show member pathways
10.92 SFTPA1 SFTPD
6
Show member pathways
10.65 SFTPA1 SFTPB SFTPC SFTPD
7
Show member pathways
10.65 ABCA3 SFTPA1 SFTPB SFTPC SFTPD

GO Terms for Neonatal Respiratory Failure

Cellular components related to Neonatal Respiratory Failure according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.72 ABCA3 SFTPA1 SFTPB SFTPC SFTPD
2 endoplasmic reticulum membrane GO:0005789 9.67 SFTPA1 SFTPB SFTPC SFTPD
3 collagen trimer GO:0005581 9.4 SFTPA1 SFTPD
4 multivesicular body lumen GO:0097486 9.26 SFTPB SFTPC
5 clathrin-coated endocytic vesicle GO:0045334 9.26 SFTPA1 SFTPB SFTPC SFTPD
6 alveolar lamellar body GO:0097208 9.16 ABCA3 SFTPB
7 lamellar body GO:0042599 8.92 SFTPA1 SFTPB SFTPC SFTPD

Biological processes related to Neonatal Respiratory Failure according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.35 ABCA3 SFTPA1 SFTPB SFTPC SFTPD
2 lipid transport GO:0006869 9.26 ABCA3 SFTPA1
3 toll-like receptor signaling pathway GO:0002224 9.16 SFTPA1 SFTPD
4 respiratory gaseous exchange GO:0007585 8.92 SFTPA1 SFTPB SFTPC SFTPD

Molecular functions related to Neonatal Respiratory Failure according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 lipid transporter activity GO:0005319 8.62 ABCA3 SFTPA1

Sources for Neonatal Respiratory Failure

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....